299 related articles for article (PubMed ID: 21494549)
1. Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.
Laczy B; Fülöp N; Onay-Besikci A; Des Rosiers C; Chatham JC
PLoS One; 2011 Apr; 6(4):e18417. PubMed ID: 21494549
[TBL] [Abstract][Full Text] [Related]
2. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
3. Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia.
Liu J; Pang Y; Chang T; Bounelis P; Chatham JC; Marchase RB
J Mol Cell Cardiol; 2006 Feb; 40(2):303-12. PubMed ID: 16337959
[TBL] [Abstract][Full Text] [Related]
4. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.
Liu J; Marchase RB; Chatham JC
J Mol Cell Cardiol; 2007 Jan; 42(1):177-85. PubMed ID: 17069847
[TBL] [Abstract][Full Text] [Related]
5. Thiamine attenuates the hypertension and metabolic abnormalities in CD36-defective SHR: uncoupling of glucose oxidation from cellular entry accompanied with enhanced protein O-GlcNAcylation in CD36 deficiency.
Tanaka T; Sohmiya K; Kono T; Terasaki F; Horie R; Ohkaru Y; Muramatsu M; Takai S; Miyazaki M; Kitaura Y
Mol Cell Biochem; 2007 May; 299(1-2):23-35. PubMed ID: 16645728
[TBL] [Abstract][Full Text] [Related]
6. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
7. The Hexosamine Biosynthesis Pathway: Regulation and Function.
Paneque A; Fortus H; Zheng J; Werlen G; Jacinto E
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107691
[TBL] [Abstract][Full Text] [Related]
8. Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine.
Nagy T; Champattanachai V; Marchase RB; Chatham JC
Am J Physiol Cell Physiol; 2006 Jan; 290(1):C57-65. PubMed ID: 16107505
[TBL] [Abstract][Full Text] [Related]
9. Chronic hexosamine flux stimulates fatty acid oxidation by activating AMP-activated protein kinase in adipocytes.
Luo B; Parker GJ; Cooksey RC; Soesanto Y; Evans M; Jones D; McClain DA
J Biol Chem; 2007 Mar; 282(10):7172-80. PubMed ID: 17227772
[TBL] [Abstract][Full Text] [Related]
10. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.
Marsh SA; Dell'Italia LJ; Chatham JC
Amino Acids; 2011 Mar; 40(3):819-28. PubMed ID: 20676904
[TBL] [Abstract][Full Text] [Related]
11. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
12. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc.
Champattanachai V; Marchase RB; Chatham JC
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C178-87. PubMed ID: 16899550
[TBL] [Abstract][Full Text] [Related]
13. The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model.
Riegger J; Baumert J; Zaucke F; Brenner RE
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298867
[TBL] [Abstract][Full Text] [Related]
14. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.
Chatham JC; Nöt LG; Fülöp N; Marchase RB
Shock; 2008 Apr; 29(4):431-40. PubMed ID: 17909453
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
[TBL] [Abstract][Full Text] [Related]
16. Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts.
Chabowski A; Momken I; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
Mol Cell Biochem; 2006 Aug; 288(1-2):201-12. PubMed ID: 16710744
[TBL] [Abstract][Full Text] [Related]
17. Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation.
Fülöp N; Zhang Z; Marchase RB; Chatham JC
Am J Physiol Heart Circ Physiol; 2007 May; 292(5):H2227-36. PubMed ID: 17208994
[TBL] [Abstract][Full Text] [Related]
18. Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels.
Marshall S; Nadeau O; Yamasaki K
J Biol Chem; 2004 Aug; 279(34):35313-9. PubMed ID: 15199059
[TBL] [Abstract][Full Text] [Related]
19. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.
Fülöp N; Marchase RB; Chatham JC
Cardiovasc Res; 2007 Jan; 73(2):288-97. PubMed ID: 16970929
[TBL] [Abstract][Full Text] [Related]
20. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
